VNRX:VolitionRX Ltd Snapshot | Charting | News | Options
$0.83 NYSE MKT LLC 8:01a ET
April 23 '24 		Nu.Q(R) Vet Cancer Test launched in-clinic in U.S. and Europe through Antech PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Nu.Q(R) Vet Cancer Test launched in-clinic in U.S. and Europe through Antech
     PR Newswire

    VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced that its Nu.Q(R) Vet Cancer Test is now available in-clinic to veterinarians across the U.S and Europe through Antech, a leading veterinary diagnostics company.

    Full Story →

    Headline News
    VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
    4:10p ET March 25 '24 PR Newswire
    VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
    8:30a ET March 21 '24 PR Newswire
    Volition and Fujifilm Vet Systems Launch Nu.Q(R) Vet Cancer Test in Japan
    8:30a ET March 20 '24 PR Newswire
    More News →
    Day  4.36%Week  35.3%Month  11.3%More Charting →
    Today, 1:23p ET Thursday April 25 '24. Markets Open.
    Last $0.83
    Day change   4.36%$0.03
    Open $0.8
    Gap at open $0.00
    Previous close $0.80
    Trading volume 256,902
    10 Day avg vol. 543,708
    Shares out. 82.1Mil
    Market cap. $68.5Mil
    Trading activity Below Avg.
    Previous data from yesterday, April 24 '24.

    Historical Price Performance
    3 month   21.97% 
    6 month   3.71% 
    1 year   47.82% 
    2 year   66.87% 

    Earnings
    Previous 12m -$0.50
    Next 12m Estimate -$0.41
    P/E ratio 1.7x
    Revenue 1Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.